Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial

Clinical trial NCT07155317 · RECRUITING

Trial details

NCT number: NCT07155317
Sponsor: Emory University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Acral Melanoma Advanced Cutaneous Melanoma Advanced Mucosal Melanoma Clinical Stage IV Cutaneous Melanoma AJCC v8 Metastatic Acral Melanoma Metastatic Cutaneous Melanoma Metastatic Mucosal Melanoma Unresectable Acral Melanoma Unresectable Cutaneous Melanoma Unresectable Mucosal Melanoma

Start date: 2025-10-29
Primary completion: 2026-12-31
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.